Your browser doesn't support javascript.
loading
Treatment with brentuximab vedotin plus bendamustine in unselected patients with CD30-positive aggressive lymphomas.
Wagner, Sandro M; Melchardt, Thomas; Egle, Alexander; Magnes, Teresa; Skrabs, Cathrin; Staber, Philipp; Simonitsch-Klupp, Ingrid; Panny, Michael; Lehner, Barbara; Greil, Richard; Keil, Felix; Jäger, Ulrich; Sillaber, Christian.
Afiliación
  • Wagner SM; 3rd Medical Department with Hematology and Medical Oncology, Paracelsus Medical University Salzburg, Salzburg, Austria.
  • Melchardt T; Salzburg Cancer Research Institute-CCCIT, Salzburg, Austria.
  • Egle A; 3rd Medical Department with Hematology and Medical Oncology, Paracelsus Medical University Salzburg, Salzburg, Austria.
  • Magnes T; Salzburg Cancer Research Institute-CCCIT, Salzburg, Austria.
  • Skrabs C; 3rd Medical Department with Hematology and Medical Oncology, Paracelsus Medical University Salzburg, Salzburg, Austria.
  • Staber P; Salzburg Cancer Research Institute-CCCIT, Salzburg, Austria.
  • Simonitsch-Klupp I; Cancer Cluster Salzburg, Salzburg, Austria.
  • Panny M; 3rd Medical Department with Hematology and Medical Oncology, Paracelsus Medical University Salzburg, Salzburg, Austria.
  • Lehner B; Salzburg Cancer Research Institute-CCCIT, Salzburg, Austria.
  • Greil R; Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
  • Keil F; Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
  • Jäger U; Clinical Institute of Pathology, Medical University of Vienna, Vienna, Austria.
  • Sillaber C; Third Medical Department for Hematology and Oncology, Hanusch Krankenhaus Wien, Vienna, Austria.
Eur J Haematol ; 104(3): 251-258, 2020 Mar.
Article en En | MEDLINE | ID: mdl-31838747
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de Hodgkin / Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma de Células T Periférico Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies Límite: Adolescent / Adult / Aged / Aged80 / Child / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Haematol Asunto de la revista: HEMATOLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Austria
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de Hodgkin / Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma de Células T Periférico Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies Límite: Adolescent / Adult / Aged / Aged80 / Child / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Haematol Asunto de la revista: HEMATOLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Austria